attachment
attachment

Radiology university exam theory write full answers properly with missing any details and points detailed answer writing

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources

JUNE 2026 - Paper 1: Complete Theory Answers


QUESTION 1

a. Cranial USG Procedure (2 marks)

Definition: Cranial ultrasonography is a portable, real-time, radiation-free imaging technique used predominantly in neonates for evaluation of intracranial structures, especially in premature infants.
Probe Used:
  • High-frequency sector probe: 5-10 MHz (7.5 MHz most commonly used in neonates)
  • A curvilinear or sector (phased array) transducer is preferred
Patient Position:
  • Supine, head in neutral or slightly extended position
Acoustic Windows:
  1. Anterior Fontanelle (primary window): Open in neonates up to 9-18 months; gives best coronal and sagittal views
  2. Posterior Fontanelle: For posterior fossa evaluation
  3. Mastoid Fontanelle (posterolateral): Best for posterior fossa and cerebellum
  4. Temporal window: For Doppler assessment of Circle of Willis
Standard Views Obtained:
Coronal Views (anterior to posterior):
  • Level of frontal horns
  • Level of foramen of Monro (caudate-thalamus groove)
  • Level of trigones/choroid plexus
  • Level of posterior horn and cerebellum
Sagittal Views:
  • Midline sagittal (corpus callosum, vermis, 4th ventricle)
  • Parasagittal views (caudothalamic groove - GMH site, choroid plexus)
Doppler: Resistive index (RI) measured from anterior cerebral artery; normal RI = 0.6-0.8 in term neonates.
Indications: Prematurity (<32 weeks), birth asphyxia, suspected IVH, hydrocephalus follow-up, seizures, macrocephaly.

b. Grading of PVL (4 marks) and GMH (4 marks)

Grading of Periventricular Leukomalacia (PVL) - De Vries / Papile Modified Classification

PVL refers to ischemic white matter injury predominantly in premature neonates, occurring in the periventricular regions (watershed zones of the premature brain).
Ultrasound-based grading (de Vries classification):
GradeUSG Findings
Grade ITransient periventricular echodensity (flare) lasting >7 days without cysts
Grade IIPeriventricular echodensity evolving into small, localized cysts (in frontal/parietal areas)
Grade IIIPeriventricular echodensity evolving into extensive periventricular cysts (extensive white matter involvement)
Grade IVPeriventricular echodensity with extensive subcortical cysts involving cortical white matter (corticosubcortical involvement)
MRI Grading (Woodward/Inder classification):
  • Mild: Minor signal abnormality, <3 foci
  • Moderate: 3 or more foci, no cysts
  • Severe: Extensive signal abnormality with or without cysts
USG features of PVL:
  • Increased periventricular echogenicity (flare) on coronal and parasagittal views
  • Symmetrical "halo" around ventricles
  • Cysts appear as anechoic areas replacing flare (after 2-3 weeks)
  • Abnormal ventricular shape - irregular outline, ex-vacuo dilatation later
  • Delayed myelination on follow-up MRI

Grading of Germinal Matrix Hemorrhage (GMH) / Intraventricular Hemorrhage (IVH) - Papile Classification (1978)

The germinal matrix (subependymal region) is highly vascular and fragile, making it prone to hemorrhage in premature neonates.
Papile Grading System (most widely used):
GradeDescription
Grade I (Subependymal hemorrhage)Hemorrhage confined to germinal matrix (caudothalamic groove); no IVH. On USG: echogenic focus at caudothalamic groove
Grade II (IVH without ventricular dilatation)Hemorrhage ruptures into ventricle filling <50% of ventricular area. USG: echogenic cast in lateral ventricle without dilatation
Grade III (IVH with ventricular dilatation)Hemorrhage fills >50% of ventricle with acute ventricular dilatation. USG: echogenic, dilated ventricle
Grade IV (Periventricular hemorrhagic infarction)Intraparenchymal hemorrhage - periventricular echogenicity extending into brain parenchyma. Most severe; due to venous infarction from obstruction of medullary veins
USG Characteristics:
  • Acute hemorrhage: Hyperechoic (echogenic)
  • Subacute (1-2 weeks): Becomes isoechoic then hypoechoic
  • Chronic: Porencephalic cyst (anechoic)
  • Best seen in parasagittal views at caudothalamic groove
Prognosis: Grade I-II - good neurological outcome; Grade III - 20-40% disability; Grade IV - high mortality and severe neurodevelopmental disability.

QUESTION 2

a. Imaging Features in a 7-year-old Male with Pyogenic Osteomyelitis (7 marks)

Pathophysiology: In children, hematogenous spread is most common. Metaphysis is the preferred site (especially distal femur, proximal tibia, proximal humerus) due to sluggish blood flow in sinusoidal vascular loops.

PLAIN RADIOGRAPHY (X-RAY):
Early phase (first 7-10 days): Often normal. Earliest finding:
  • Soft tissue swelling - obliteration of fat planes around bone
  • Loss of soft tissue planes
  • Periosteal reaction may be absent early
Late phase (after 10-14 days):
  • Lytic metaphyseal lesion (permeative pattern)
  • Periosteal reaction - aggressive (laminated/"onion skin" or Codman's triangle)
  • Cortical destruction
  • Subperiosteal abscess (periosteal elevation)
  • Soft tissue mass adjacent to bone
  • Sequestrum (dead bone: dense avascular fragment)
  • Involucrum (periosteal new bone surrounding sequestrum)
  • Cloaca (sinus tract through cortex)
  • Brodie's abscess (loculated lucency with sclerotic rim - subacute form)

ULTRASOUND:
  • Earliest modality to show subperiosteal abscess (hyperechoic or complex fluid between periosteum and cortex)
  • Soft tissue edema and deep tissue abscess
  • Periosteal elevation - distance >2mm is significant
  • Power Doppler: Increased vascularity around abscess wall
  • Cartilage involvement in neonates and young children
  • Useful for image-guided aspiration

BONE SCINTIGRAPHY (Tc-99m MDP):
  • 3-phase bone scan: sensitive within 24-72 hours
  • Phase 1 (flow) and Phase 2 (blood pool): Increased activity in inflammation
  • Phase 3 (delayed): Increased uptake in osteomyelitis
  • False negative in neonates (avascular necrosis pattern - "cold" lesion)
  • Sensitivity ~80-90%; helpful for multifocal disease

CT SCAN:
  • Better bone detail than MRI
  • Shows: cortical destruction, periosteal reaction, sequestrum, involucrum, cloaca
  • Soft tissue abscess
  • Intramedullary gas (very specific)
  • Used for guided biopsy
  • Limitation: radiation dose in children

MRI (Gold Standard):
Sequences:
  • T1W: Normal marrow replaced by low signal
  • T2W/STIR: High signal in medullary cavity (edema/pus)
  • Fat-suppressed T2: Best for marrow edema
  • T1W+Gd contrast: Rim-enhancing abscess; differentiates phlegmon from abscess
Specific findings:
  • Marrow edema: Low T1, high T2/STIR signal in metaphysis
  • Phlegmon: Ill-defined marrow abnormality without rim enhancement
  • Abscess: Well-defined rim-enhancing collection (T1 dark center, T2 bright)
  • Subperiosteal abscess: Lenticular fluid collection under periosteum
  • Periosteal reaction and soft tissue edema
  • Epiphyseal spread (via cartilaginous channels in children <18 months)
  • Joint involvement (septic arthritis)
  • Sinus tract: Linear T2 high signal channel through cortex to skin
MRI Superiority: Multi-planar capability, early marrow changes (within 24-48 hours), assessment of extent, cartilage and growth plate involvement.

b. Differential Diagnoses of Pyogenic Osteomyelitis in Children (3 marks)

  1. Ewing's Sarcoma: Aggressive periosteal reaction (sunburst/onion skin), permeative lysis in diaphysis, large soft tissue mass, systemic symptoms mimic infection
  2. Langerhans Cell Histiocytosis (LCH): Punched-out lytic lesions, vertebra plana, periosteal reaction; eosinophilic granuloma
  3. Leukemia: Permeative lysis, metaphyseal lucent bands, periosteal reaction, multifocal
  4. Septic Arthritis (contiguous spread): Joint space widening, periarticular swelling
  5. Bone lymphoma: Aggressive permeative pattern
  6. Stress fracture: History of physical activity, no systemic signs
  7. Chronic recurrent multifocal osteomyelitis (CRMO): Multifocal, non-infective inflammatory

QUESTION 3

Acromegaly: Imaging Workup (10 marks)

Definition: Acromegaly is a disease of excess growth hormone (GH) secretion after closure of epiphyses, most commonly due to a pituitary GH-secreting adenoma.

I. MRI Pituitary (Investigation of Choice)

Protocol:
  • 3T MRI preferred; thin slices (2-3mm) through pituitary fossa
  • Coronal and sagittal T1W, T2W
  • Dynamic contrast-enhanced coronal T1W (key for microadenoma)
  • T2W: Adenoma often isointense to slightly hypointense to brain
  • Post-gadolinium: Normal pituitary enhances brightly; adenoma enhances less (hypointense in early phase)
Findings:
  • Macroadenoma (>10mm): Most common in acromegaly
    • Enlargement of pituitary fossa/sella turcica
    • Suprasellar extension - "snowman" or "figure of 8" appearance
    • Optic chiasm compression (bitemporal hemianopia)
    • Cavernous sinus invasion (encircling carotid artery - Knosp grading)
    • Sphenoid sinus invasion
    • T1: Iso/hypointense; T2: Variable; post-contrast: Heterogeneous enhancement
  • Microadenoma (<10mm): Less common in acromegaly
    • Off-center pituitary gland
    • Contralateral tilt of stalk
    • Asymmetric enlargement of sella
Post-operative MRI: At 3 months, then annually; to detect residual/recurrent tumor.

II. Skull and Facial Bones (Plain X-ray)

  • Skull X-ray:
    • Enlarged sella turcica (>23mm wide, >17mm deep - "ballooned sella")
    • Double floor of sella (adenoma extension)
    • Thickening of calvarium (frontal bone)
    • Increased skull base thickness
    • Prognathism - elongation of mandible
    • Enlarged frontal sinuses (pneumosinus dilatans)
    • Increased skull density
  • Facial bones:
    • Prognathism (protruding jaw)
    • Enlarged mandibular condyles
    • Widened mandibular angle
    • Widely spaced teeth (diastema)

III. Hands and Feet (X-ray)

Hands:
  • Broad, "spade-like" hands
  • Increased thickness of soft tissue (soft tissue hypertrophy)
  • "Arrowhead" or "spade-like" terminal phalangeal tufts (widened)
  • Widened joint spaces (cartilage hypertrophy)
  • Premature osteoarthritis
  • Sesamoid index (sum of sesamoid dimensions) >40mm² in women, >72mm² in men - diagnostic
Feet:
  • Heel pad thickness >21mm in females, >23mm in males = DIAGNOSTIC (most reliable plain film sign)
  • Wide, square-shaped metatarsals
  • Soft tissue hypertrophy

IV. Spine (X-ray / MRI)

  • Posterior vertebral body scalloping (due to dural ectasia)
  • Increased anteroposterior diameter of vertebral bodies
  • Disc space widening
  • Dorsal kyphosis
  • Vertebral osteophytes (spondylosis)
  • Spinal canal widening

V. Chest X-ray

  • Cardiomegaly (acromegalic cardiomyopathy)
  • Rib thickening/elongation
  • Sternal deformity
  • Barrel chest appearance

VI. Other Imaging

  • CT Chest/Abdomen: To detect ectopic GH-secreting tumor (rare source - bronchial carcinoid, pancreatic tumor)
  • Echocardiography: Concentric LVH, diastolic dysfunction, valvular disease
  • Somatostatin receptor scintigraphy / Ga-68 DOTATATE PET-CT: For ectopic GHRH/GH source
  • CT sinuses: Enlarged sinuses (diagnostic hallmark)
  • Lateral cervical spine X-ray: Atlantoaxial subluxation (due to ligamentous laxity)
  • DXA scan: Osteoporosis assessment (hypogonadism secondary to tumor compression)

Summary of Key Diagnostic Imaging

ModalityKey Finding
MRI pituitaryMacroadenoma (gold standard for tumor)
X-ray skullEnlarged sella, prognathism, frontal bossing
X-ray handsSpade-like tufts, sesamoid index
X-ray feetHeel pad thickness >23mm
X-ray spinePosterior vertebral scalloping
DOTATATE PET-CTEctopic source

QUESTION 4

a. Glioma Imaging Features (5 marks)

Definition: Gliomas are primary brain tumors arising from glial cells (astrocytes, oligodendrocytes, ependymal cells). WHO classifies them Grade I-IV.

LOW-GRADE GLIOMA (Grade I-II):
CT Scan:
  • Hypodense to isodense lesion
  • No significant mass effect
  • Absent or minimal contrast enhancement (blood-brain barrier intact)
  • Calcification in ~20% (especially oligodendroglioma)
  • No edema or minimal edema
MRI:
  • T1W: Hypointense (dark)
  • T2W/FLAIR: Hyperintense (bright) - "bright T2 lesion"
  • No or minimal enhancement on T1W+Gd
  • Cortical expansion without mass effect
  • Smooth borders (relatively)
  • No restricted diffusion (high ADC values)
  • Low rCBV on perfusion (low vascularity)
  • DWI: No restriction
  • MRS: Mildly elevated Cho, reduced NAA, no lactate

HIGH-GRADE GLIOMA / GLIOBLASTOMA MULTIFORME (GBM - Grade IV):
CT Scan:
  • Heterogeneous hypodense/isodense mass
  • Vivid ring enhancement (thick, irregular) post contrast
  • Central necrosis (hypodense)
  • Surrounding vasogenic edema (finger-like white matter edema)
  • Mass effect - midline shift, herniation
  • "Butterfly glioma" - crosses corpus callosum to contralateral side (diagnostic feature)
  • Hemorrhagic foci (heterogeneous density)
  • Multifocal in 2-5%
MRI:
  • T1W: Hypointense, central dark necrosis, surrounding mass
  • T2W: Heterogeneous hyperintense mass with bright edema; necrosis dark
  • FLAIR: Extensive surrounding hyperintensity (edema + infiltrating tumor)
  • T1W+Gd: Irregular, thick ring enhancement with non-enhancing necrotic center
  • DWI: Restricted diffusion in cellular viable tumor portions (low ADC)
  • SWI/GRE: Hemorrhagic foci - "blooming" artifacts
  • MRS: High Cho/NAA ratio (>2), elevated Cho peak, reduced NAA, lipid/lactate peak (necrosis)
  • Perfusion (DSC): High rCBV in enhancing rim (tumor) - >2x normal white matter

OLIGODENDROGLIOMA:
  • Cortical-based "cortical" location (frontal most common)
  • Calcification in 70-90% (CT: "gyriform" calcification)
  • Minimal/absent edema
  • 1p/19q co-deletion (molecular marker - better prognosis)
  • T2/FLAIR hyperintense, minimal enhancement

EPENDYMOMA:
  • 4th ventricle (posterior fossa) in children; spinal canal and supratentorial in adults
  • "Plastic" tumor - molds to CSF spaces, squeezes through foramina of Luschka/Magendie
  • Mixed density/signal (cysts, calcification, hemorrhage)
  • Heterogeneous enhancement
  • Can drop metastases in spine ("drop mets")

b. Role of MR Perfusion in Glioma (5 marks)

MR Perfusion: Evaluates tumor vascularity and capillary permeability - surrogate marker for angiogenesis/grade.

Types of MR Perfusion:
  1. DSC (Dynamic Susceptibility Contrast) Perfusion:
    • Most widely used
    • Uses T2* signal drop after gadolinium bolus
    • Measures: rCBV (relative cerebral blood volume), rCBF, MTT
    • Key parameter: rCBV (reflects angiogenesis)
  2. DCE (Dynamic Contrast Enhanced) Perfusion:
    • T1-based; measures Ktrans (volume transfer coefficient)
    • Reflects capillary permeability
    • Useful for anti-VEGF therapy monitoring
  3. ASL (Arterial Spin Labeling):
    • No contrast needed
    • Labels blood water protons as endogenous tracer
    • Measures CBF
    • Useful in pediatric patients

Clinical Applications in Glioma:
1. Tumor Grading:
  • High-grade glioma: rCBV >1.75-2.0x (elevated) - high angiogenesis
  • Low-grade glioma: rCBV <1.5x - low vascularity
  • Correlation: rCBV correlates with histological grade and VEGF expression
2. Distinguishing Tumor from Radiation Necrosis:
  • Radiation necrosis: Low rCBV (<0.6x), low Ktrans (disrupted but hypovascular)
  • Tumor recurrence/progression: High rCBV (>1.5-2.0x), high Ktrans
  • This is crucial post-treatment follow-up: MRI alone cannot distinguish
3. Biopsy Targeting:
  • Guides stereotactic biopsy to the highest-grade, most vascular portion of the tumor (hot spot)
  • Prevents sampling error (avoiding necrotic/non-diagnostic areas)
4. Treatment Response Assessment:
  • "Pseudo-progression" (early post-treatment): Enhancement increases transiently but rCBV is low - favors radiation effect
  • True progression: Increasing rCBV confirms tumor growth
  • Anti-VEGF therapy monitoring: Normalization of rCBV/Ktrans indicates response; re-elevation indicates failure
5. Extent of Infiltration:
  • Non-enhancing T2/FLAIR hyperintense region: Perfusion shows elevated rCBV - indicates infiltrating tumor beyond enhancing margin (relevant for surgical planning)
6. Prognosis:
  • Higher rCBV correlates with shorter overall survival in GBM
  • Helps stratify patients for aggressive vs. palliative management

Summary Table:
ApplicationKey ParameterFinding
High-grade gliomarCBV>1.75-2.0
Radiation necrosisrCBV<0.6
True recurrencerCBV>1.5
Pseudo-progressionrCBVLow despite new enhancement

QUESTION 5

a. Enumerate Salivary Gland Tumors (2 marks)

Benign Tumors:
  1. Pleomorphic adenoma (mixed tumor) - Most common (65-70%)
  2. Warthin's tumor (papillary cystadenoma lymphomatosum)
  3. Oncocytoma (oxyphilic adenoma)
  4. Basal cell adenoma
  5. Myoepithelioma
  6. Canalicular adenoma
  7. Ductal papilloma
  8. Hemangioma (children)
  9. Lipoma
Malignant Tumors:
  1. Mucoepidermoid carcinoma (Most common malignant - parotid)
  2. Adenoid cystic carcinoma (Most common - submandibular/minor glands; perineural spread)
  3. Carcinoma ex-pleomorphic adenoma (malignant transformation)
  4. Acinic cell carcinoma
  5. Polymorphous adenocarcinoma
  6. Squamous cell carcinoma (primary)
  7. Lymphoma (primary or secondary)
  8. Metastases
Rule: 80% of parotid tumors benign, 80% of those = pleomorphic adenoma ("rule of 80s")

b. Imaging of Pleomorphic Adenoma (4 marks)

Most common salivary gland tumor; most common in parotid (superficial lobe).
Ultrasound:
  • Well-defined, smoothly marginated, hypoechoic mass
  • Lobulated contour (lobulated/bosselated border)
  • Posterior acoustic enhancement (soft tissue mass)
  • Internal homogeneous texture when small; heterogeneous when large
  • Color Doppler: Internal vascularity (central and peripheral)
CT Scan:
  • Well-circumscribed, homogeneous or slightly heterogeneous mass
  • Isodense to soft tissue; hypodense areas = myxoid stroma
  • Moderate, homogeneous enhancement post-contrast
  • Calcification in ~20%
  • No invasion of surrounding structures
  • Facial nerve plane preserved
MRI (Best modality):
  • T1W: Isointense to hypointense to muscle
  • T2W: Characteristically VERY BRIGHT (hyperintense) - due to high water content (myxoid/chondroid stroma) - "light bulb" T2 brightness
  • T1W+Gd: Moderate enhancement; may show capsular enhancement
  • Well-defined smooth/lobulated margins
  • DWI: Intermediate to low diffusion restriction (ADC ~1.4-1.6 x 10-3 mm²/s)
  • Capsule visible as T1/T2 dark rim
Key Feature: Very high T2 signal is the hallmark of pleomorphic adenoma; distinguishes from Warthin's and malignant tumors.

c. Imaging of Warthin's Tumor (4 marks)

Also called: Papillary cystadenoma lymphomatosum; second most common benign parotid tumor.
Characteristic Features: Bilateral in 10%, multifocal, exclusively in parotid (tail of parotid), almost exclusively in middle-aged males.
Ultrasound:
  • Well-defined, smoothly marginated
  • Mixed echotexture: Solid and cystic components
  • Multiple anechoic cysts within hypoechoic solid stroma ("sponge-like" appearance)
  • Posterior acoustic enhancement
  • Color Doppler: Increased vascularity (hilar pattern)
CT Scan:
  • Well-defined parotid mass
  • Mixed density - solid component isodense + cystic areas
  • Vivid enhancement of solid portions
  • May appear bilateral in 10% cases (virtually diagnostic when bilateral in tail of parotid)
  • No calcification (unlike pleomorphic adenoma)
  • Slightly higher density than pleomorphic adenoma (less water content)
MRI:
  • T1W: Intermediate-to-high signal (protein-rich cystic fluid - high T1) - key distinguishing feature from pleomorphic adenoma
  • T2W: Heterogeneous - intermediate (NOT as bright as pleomorphic adenoma)
  • T1W+Gd: Enhancement of solid portions; cysts do not enhance
  • DWI: Variable ADC; intermediate restriction
  • High T1 signal (due to mucin/proteinaceous content) differentiates from pleomorphic adenoma
Nuclear Medicine:
  • Tc-99m pertechnetate scan: HOT SPOT (increased uptake) in Warthin's - due to oncocytic cells concentrating pertechnetate; pathognomonic feature
Key Differentiating Features: Pleomorphic vs. Warthin's:
FeaturePleomorphicWarthin's
T2 signalVery brightIntermediate/heterogeneous
T1 signalLowHigh (proteinaceous)
BilateralityRare10%
Tc-99m scanColdHot
LocationAny lobeTail of parotid

QUESTION 6

a. Enumerate Causes of Leukokoria (2 marks)

Leukokoria = white pupillary reflex (absent red reflex)
  1. Retinoblastoma (most common cause in children - must exclude first)
  2. Persistent Fetal Vasculature (PFV) / Persistent Hyperplastic Primary Vitreous (PHPV)
  3. Coats' disease (retinal telangiectasia with exudative retinal detachment)
  4. Congenital cataract
  5. Retinopathy of prematurity (ROP) - Stage 4/5
  6. Toxocariasis (ocular larva migrans)
  7. Vitreous hemorrhage (organizing)
  8. Endophthalmitis
  9. Norrie disease
  10. Familial exudative vitreoretinopathy (FEVR)
  11. Myelinated nerve fibers
  12. Coloboma

b. USG Findings of Leukokoria (4 marks)

Retinoblastoma:
  • Intraocular mass with calcifications (80-90% - highly echogenic foci with posterior acoustic shadowing)
  • Hyperdense solid mass in posterior segment
  • Detached retina may be visible
  • Color Doppler: Internal vascularity
PFV (PHPV):
  • Microphthalmic eye (small eye - key distinguishing feature)
  • Echogenic retrolental membrane (Cloquet's canal remnant)
  • No calcification
  • Funnel-shaped retinal detachment
  • Linear echogenic strand from lens to disc (persistent hyaloid vascularity)
  • Color Doppler: May show flow in hyaloid artery
Coats' Disease:
  • Subretinal exudate - highly echogenic material in vitreous/subretinal space
  • Retinal detachment (exudative - V-shaped or total)
  • No calcification (unlike retinoblastoma)
  • Normal-sized eye
  • No intraocular mass
  • Yellow subretinal fluid on ultrasound (proteinaceous)
Toxocariasis:
  • Peripheral granuloma or vitreous mass
  • Echogenic focus at posterior pole or periphery
  • Vitreous membranes/strands
  • Traction retinal detachment
ROP Stage 4-5:
  • Funnel-shaped or total retinal detachment
  • No calcification
  • Premature infant history

c. Retinoblastoma CT Findings (4 marks)

Most common intraocular malignancy in children (age 2-3 years); may be unilateral (75%) or bilateral (25%).
CT Scan (Protocol: thin sections, both eyes):
Key Findings:
  1. Calcification (PATHOGNOMONIC):
    • Present in 80-95% of cases
    • Irregular, "chunky" or "flocculent" calcification within intraocular mass
    • Best demonstrated on CT
    • Calcification in an intraocular mass in a child <3 years = retinoblastoma until proven otherwise
  2. Intraocular Mass:
    • Hyperdense to vitreous on pre-contrast CT
    • Arises from retina (posterior segment)
    • May be endophytic (into vitreous), exophytic (into subretinal space), or mixed
    • "Snowball-like" calcification pattern
  3. Retinal Detachment:
    • Subretinal fluid/exudate
    • Detached retina visible as linear density
  4. Contrast Enhancement:
    • Post-contrast: Heterogeneous enhancement of solid tumor component
    • Calcified areas do not enhance
  5. Size and Extension:
    • Small tumors confined to globe (Stage I/II)
    • Choroidal invasion, scleral invasion (intermediate stages)
    • Optic nerve extension: Critical - thickening/enhancement of optic nerve behind globe
    • Extraocular extension: Proptosis, periorbital soft tissue mass
  6. Orbital and Intracranial Extension:
    • Invasion through sclera into orbit
    • Intracranial extension via optic nerve to chiasm and brain (Stage V)
    • Pineal region mass ("trilateral retinoblastoma" - bilateral RB + pineoblastoma)
    • Leptomeningeal spread
  7. Bilateral Disease:
    • Both eyes should always be imaged
    • Heritable form (Rb1 gene mutation) - bilateral in 25%, higher risk of secondary tumors
Differential Diagnosis on CT:
  • PFV: No calcification, microphthalmic eye, retrolental membrane
  • Coats' disease: No calcification, no intraocular mass
  • Toxocariasis: No calcification, older child, peripheral lesion
Role of MRI: Better for optic nerve extension, intracranial spread, soft tissue detail (avoid CT when possible due to radiation concern with hereditary Rb)

QUESTION 7

a. Anatomy of Brachial Plexus (3 marks)

Formation: Anterior rami of C5, C6, C7, C8, T1; contributions from C4 (prefixed) and T2 (postfixed).
Structure:
Roots → Trunks → Divisions → Cords → Branches
ROOTS: C5, C6, C7, C8, T1
  • Emerge between anterior and middle scalene muscles (scalenus anterior and medius)
  • "5 roots between the scalenes"
TRUNKS (3):
  • Upper (superior) trunk: C5 + C6
  • Middle trunk: C7 alone
  • Lower (inferior) trunk: C8 + T1
  • Located in posterior triangle of neck
DIVISIONS (6): Each trunk divides into anterior and posterior
  • Upper trunk → anterior + posterior
  • Middle trunk → anterior + posterior
  • Lower trunk → anterior + posterior
CORDS (3): Named by relation to 2nd part of axillary artery
  • Lateral cord: Anterior divisions of upper + middle trunks (C5,6,7)
  • Medial cord: Anterior division of lower trunk (C8, T1)
  • Posterior cord: ALL THREE posterior divisions (C5,6,7,8,T1)
  • Located in axilla (retropectoral space)
TERMINAL BRANCHES (5 major):
  • Musculocutaneous nerve (C5,6,7) - from lateral cord
  • Median nerve (C5-T1) - from lateral + medial cords (dual root)
  • Ulnar nerve (C8,T1) - from medial cord
  • Radial nerve (C5-T1) - from posterior cord
  • Axillary nerve (C5,6) - from posterior cord
Other named branches:
  • Long thoracic nerve (C5,6,7 - roots): Serratus anterior
  • Dorsal scapular nerve (C5): Rhomboids
  • Suprascapular nerve (C5,6 - upper trunk): Supraspinatus + infraspinatus
  • Thoracodorsal nerve (C6,7,8 - posterior cord): Latissimus dorsi
Erb's Point: Junction of C5 and C6 at upper trunk; Erb's palsy from upper trunk injury (waiter's tip deformity) Klumpke's palsy: Lower trunk (C8,T1) injury - claw hand

b. Role of MR Neurography in Brachial Plexopathy (7 marks)

Definition: MR Neurography (MRN) is a specialized high-resolution MRI technique that selectively visualizes peripheral nerves using specific sequences to suppress background signal.

MRN Technique for Brachial Plexus:
  • 3T MRI preferred (higher SNR)
  • Coil: Phased array surface coil / neurovascular coil
  • Sequences:
    • Coronal STIR (Short TI Inversion Recovery): T2-weighted with fat suppression - abnormal nerves appear bright
    • 3D SPACE/CUBE/VISTA (3D FSE): Isotropic voxels, multiplanar reformats
    • T1W: For anatomical localization and mass lesions
    • DWI of nerves: Fascicular pattern; ADC changes in injury
    • DTI (Diffusion Tensor Imaging): Tractography of plexus; FA (fractional anisotropy) changes in injury
    • DWIBS (Diffusion Weighted Whole Body Imaging with Background Suppression): Like "MR PET" for nerve tumors
    • MR myelography: Intrathecal root avulsion (pseudomeningoceles)

Normal Brachial Plexus on MRN:
  • Nerves appear as linear, smoothly coursing structures
  • Slight T2/STIR hypersignal compared to muscle
  • Uniform caliber
  • Preserved fascicular architecture

Abnormal Findings in Brachial Plexopathy:
1. Traumatic Plexopathy (Birth injury / High-velocity trauma):
  • Pre-ganglionic (root avulsion):
    • Pseudomeningocele (CSF-filled dural sleeve at avulsion site - diagnostic)
    • Bare rootlets in thecal sac (empty root sleeve)
    • Best seen on MR myelography / CT myelography
    • Empty root sleeve on coronal images
    • Cord injury possible (contusion/signal change)
  • Post-ganglionic:
    • Nerve discontinuity, neuroma formation
    • T2/STIR hyperintensity of involved nerves
    • Nerve retraction with fibrotic scarring
    • Muscle denervation changes: STIR hyperintensity in acute (denervation edema), fatty atrophy in chronic
2. Neoplastic Plexopathy:
  • Lung apex (Pancoast tumor): T1W hypointense mass invading lower trunk (C8,T1)
  • Direct mass infiltration of plexus; nerve thickening/displacement
  • Lymph node involvement (axillary, supraclavicular)
  • MRN shows: Asymmetric nerve enlargement, T2 hyperintensity, loss of fascicular pattern
  • Carcinoma of breast: Direct extension or nodal compression
  • Nerve sheath tumors (neurofibroma, schwannoma): Well-defined T2 bright fusiform masses, "target sign" (central T2 dark, peripheral T2 bright)
3. Radiation Plexopathy:
  • Common after breast/lung radiation
  • MRN: Diffuse T2 hyperintensity of all nerves within radiation field (vs. neoplasm which is focal/asymmetric)
  • No discrete mass
  • Fibrosis: Loss of fat planes, tethering
  • Key: Radiation affects entire field; tumor affects specific trunks/cords
  • Gadolinium: No enhancement (radiation necrosis) vs. tumor (enhancement)
4. Thoracic Outlet Syndrome (TOS):
  • Vascular MRI/MRA: Subclavian artery compression
  • Nerve compression: T2 hyperintensity, caliber change
  • Dynamic MRN with arm positioning (elevated vs. neutral)
  • Accessory rib (cervical rib) - seen on plain X-ray and MRI
5. Inflammatory / Parsonage-Turner Syndrome (Neuralgic Amyotrophy):
  • MRN: Segmental T2 hyperintensity ("beaded pattern")
  • Hourglass-like constriction (fascicular constriction) - pathognomonic
  • Denervation in muscles (STIR hyperintensity)
  • Often self-limiting

DTI and Tractography:
  • FA (Fractional Anisotropy) reduced in injured nerves
  • ADC elevated in inflammatory/edematous nerves
  • 3D fiber tractography: Visualizes nerve continuity, guides surgical exploration
  • Predicts surgical prognosis (complete avulsion vs. partial injury)
Clinical Importance of MRN:
  • Guides surgical planning (neurolysis vs. nerve grafting vs. nerve transfer)
  • Distinguishes pre vs. post-ganglionic injury (critical for prognosis)
  • Differentiates tumor vs. radiation vs. traumatic plexopathy
  • Identifies treatable compressive lesion (TOS, mass)

QUESTION 8

Rheumatoid Arthritis (RA) - Imaging

a. Imaging Features in the Hand (4 marks)

Order of imaging modalities: X-ray first, then USG, then MRI.

Plain X-ray (Conventional Radiograph - posteroanterior view of both hands):
Early RA (first 1-2 years):
  1. Periarticular soft tissue swelling - fusiform swelling around MCP and PIP joints
  2. Periarticular osteopenia - juxta-articular bone demineralization
  3. Joint effusion - soft tissue density in joint space
Moderate RA: 4. Uniform joint space narrowing - symmetric, due to global cartilage destruction (contrast with OA: asymmetric) 5. Erosions - "bare area erosions" at the edges of joints (unprotected by cartilage); starts at MCP joints (2nd and 3rd most common) 6. "Rat bite" or "mouse bite" erosions at joint margins 7. Periarticular osteoporosis progressing to generalized osteoporosis
Advanced RA: 8. Deformities:
  • Swan neck deformity (PIP hyperextension, DIP flexion)
  • Boutonniere deformity (PIP flexion, DIP hyperextension)
  • Ulnar deviation/drift at MCP joints
  • Z-thumb deformity (MCP flexion + IP hyperextension)
  • "Piano key" deformity of ulnar head
  1. Subluxation at MCP joints (volar subluxation)
  2. Ankylosis (bony fusion - late stage, especially in wrist carpus)
  3. Carpal crowding - collapse of carpal height
  4. Boutonniere deformity of fingers
Ultrasound:
  • Synovial thickening (pannus): Hypoechoic to anechoic thickening in joint
  • Joint effusion: Anechoic fluid
  • Power Doppler: Active synovitis - increased vascularity in pannus (confirms active disease)
  • Erosions: Cortical breaks at bare areas
  • Tenosynovitis: Fluid around tendons (flexor tendons)
  • Extra-articular: Rheumatoid nodules (hypoechoic/anechoic subcutaneous nodules)
MRI:
  • Synovitis: T1+Gd enhancement of thickened synovium (pannus)
  • Bone marrow edema (STIR/T2): Precedes erosions on X-ray by months
  • Erosions: T1 cortical defect filled with T2 bright pannus
  • Cartilage loss: T1W thin/absent cartilage
  • Tendon rupture/tenosynovitis: T2 hyperintense fluid around tendon
  • MRI can detect erosions 6-12 months before X-ray

b. Imaging Features in the Wrist (4 marks)

Plain X-ray:
  1. Carpal bones:
    • Erosions at carpal bones - especially triquetrum, pisiform, scaphoid (bare area erosions)
    • Uniform joint space narrowing of radiocarpal and intercarpal joints
    • Periarticular osteoporosis
    • Carpal crowding/collapse (decreased carpal height ratio)
    • Bony ankylosis in late disease (fused carpal bones - "carpal coalition")
  2. Distal Radioulnar Joint (DRUJ):
    • DRUJ erosions/widening
    • "Piano key" deformity: Dorsal subluxation of distal ulna
    • Caput ulnae syndrome: Erosive destruction of distal ulna with dorsal subluxation
  3. Radiocarpal joint:
    • Uniform joint space narrowing
    • Radial deviation of carpus (while fingers ulnar deviate)
    • Erosions of radial styloid process
  4. Tenosynovitis:
    • Extensor tendon compartments (EPL, EDC) - USG: Fluid sheath
    • Extensor carpi ulnaris (ECU) most commonly involved
  5. Carpal tunnel syndrome: Secondary RA involvement, USG: Enlarged median nerve, flexor tenosynovitis
MRI Wrist:
  • DRUJ synovitis and effusion
  • TFCC (triangular fibrocartilage complex) tear/erosion
  • Ulnar styloid erosion
  • Carpal bone marrow edema
  • Tendon rupture (Vaughan-Jackson syndrome: sequential extensor tendon ruptures beginning at EDM)
  • Extensor and flexor tenosynovitis
  • Carpal tunnel median nerve compression

c. Differential Diagnoses of RA (2 marks)

  1. Osteoarthritis (OA): Asymmetric joint space narrowing, osteophytes, subchondral sclerosis, no erosions; affects DIP > PIP > 1st CMC (spares MCP); no osteoporosis
  2. Psoriatic Arthritis: "Ray" distribution, DIP involvement, "pencil-in-cup" deformity, sausage digits, new bone formation (periostitis), HLA-B27
  3. Gout: Tophi (punched-out erosions with overhanging edges - "rat bite"), asymmetric, 1st MTP joint (podagra), no osteoporosis
  4. Systemic Lupus Erythematosus (SLE/Jaccoud's arthropathy): Reducible deformities without erosions; periarticular soft tissue changes; no true erosions
  5. Reactive Arthritis (Reiter's syndrome): Lower limbs predominantly, calcaneal spur, HLA-B27
  6. Juvenile Idiopathic Arthritis (JIA): Age <16, periosteal reaction, overgrowth of epiphyses, micrognathia (TMJ involvement)

QUESTION 9

a. Enumerate Extradural Spinal Tumors (3 marks)

Extradural (outside the dura):
Primary Osseous/Vertebral:
  1. Metastases (most common extradural mass - breast, lung, prostate, kidney, thyroid)
  2. Multiple myeloma / plasmacytoma
  3. Osteosarcoma
  4. Chordoma (sacrococcygeal)
  5. Giant cell tumor (sacrum, vertebral body)
  6. Osteoblastoma
  7. Aneurysmal bone cyst
  8. Hemangioma (vertebral)
  9. Ewing's sarcoma
Soft Tissue Extradural: 10. Epidural abscess (infection) 11. Epidural hematoma 12. Lymphoma (epidural extension) 13. Nerve sheath tumors (neurofibroma, schwannoma) extending epidurally 14. Lipomatosis (epidural lipomatosis - steroid-induced) 15. Meningioma (rare extradural)

b. Imaging Features of Extradural Spinal Tumors (4 marks)

Plain X-ray:
  • Vertebral body collapse/destruction
  • Pedicle erosion ("winking owl" sign - loss of pedicle shadow on AP view)
  • Paravertebral soft tissue mass
  • Sclerotic vertebral body (blastic metastasis - prostate, breast)
  • Lytic vertebral body (lytic metastasis - lung, kidney)
CT Scan:
  • Vertebral body/pedicle destruction
  • Paravertebral/epidural soft tissue mass
  • Extent of cortical destruction
  • Soft tissue extension into spinal canal
  • Heterogeneous mass with areas of lysis/sclerosis
  • Metastases: Multiple level involvement
  • Chordoma: Sacrococcygeal destructive mass, calcification, "sentinel" lesion
  • Epidural abscess: Rim-enhancing fluid collection
MRI (Gold Standard):
Signal characteristics:
  • Metastases:
    • T1W: Low signal replacing normal fatty marrow (high T1)
    • T2W: High signal (most)
    • STIR: High signal (sensitive for marrow replacement)
    • T1+Gd: Enhancement of tumor
    • "Halo sign" on STIR: Surrounding marrow edema
    • Convex posterior cortex/epidural disease
    • Posterior cortical destruction
    • Epidural component: Soft tissue epidural mass
  • Epidural space (extradural) characteristics:
    • Mass is OUTSIDE the dura: CSF signal displaced inward
    • "Tenting" of the dura
    • Normal epidural fat obliterated
    • No intradural contrast pooling
Specific features:
  • Metastases: Multiple levels, T1 low replacing normal bright marrow, gadolinium enhancement
  • Epidural hematoma: Biconvex, T1 bright (acute/subacute), T2 variable; post-traumatic
  • Epidural abscess: Rim-enhancing dorsal epidural collection; T2 bright; adjacent spondylodiscitis
  • Hemangioma: "Corduroy" pattern on X-ray, T1 AND T2 bright (fat and vascular channels)
  • Chordoma: T2 very bright (notochordal tissue), low T1, enhances moderately; presacral mass

c. Difference Between Intradural and Extradural Spinal Tumors (4 marks)

FeatureExtradural TumorIntradural Tumor
LocationOutside the dura (epidural space, vertebral body)Inside the dura
Subtypes-Extramedullary (outside cord) vs. Intramedullary (within cord)
ExamplesMetastases, lymphoma, epidural abscess, hematomaMeningioma, neurofibroma, ependymoma, astrocytoma
Most commonMetastases (most common overall)Meningioma (intradural extramedullary), ependymoma (intramedullary)
Cord relationshipDisplaces cord + dura togetherExtramedullary displaces cord only; intramedullary expands cord
DuraDura displaced/invadedDura intact; tumor inside
CSF spaceObliterated on side of mass; displaced contralaterallyWidened ipsilaterally (golf tee sign - IDEM); cord expanded (IMT)
MRI signVertebral body involvement; obliterated epidural fat; no CSF cap"Cap sign" (CSF capping tumor - IDEM); cord widening (IMT)
Dural tailAbsentPresent in meningioma (intradural)
EnhancementRim (abscess), homogeneous/heterogeneous (mets)Homogeneous (meningioma, neurofibroma), ependymoma (heterogeneous)
Vertebral involvementCommon (destruction, marrow replacement)Uncommon
MyelographyComplete block at level; extradural indentation ("meniscus sign")Intradural block with "golf tee sign" (IDEM)
PrognosisOften metastatic disease (poor)Many benign; surgical cure possible
Additional MRI Distinguishing Features:
  • Extradural: The dura drapes over the mass ("tenting sign"); epidural fat obliterated; posterior cortical wall destruction of vertebral body; mass spans multiple levels.
  • Intradural Extramedullary (IDEM - e.g., meningioma, schwannoma):
    • "Golf tee sign" on myelography
    • "Cap sign" on MRI (CSF above and below lesion)
    • Spinal cord displaced to contralateral side
    • Acute angle of the mass with cord/dura
    • Homogeneous enhancement; dural tail (meningioma)
  • Intramedullary (IMT - e.g., ependymoma, astrocytoma):
    • Cord expansion and widening
    • Syrinx/cyst within or adjacent to tumor
    • Ependymoma: Central canal origin, well-defined, "cap sign" (hemosiderin at poles), homogeneous enhancement
    • Astrocytoma: Ill-defined, eccentric, heterogeneous, indistinct margins

QUESTION 10

a. Moon Mass Enhancement (5 marks)

Note: The question says "atoon mass enhancement" - this is interpreted as "Tumor mass enhancement" and specifically refers to enhancement patterns of masses on contrast imaging.
Enhancement Patterns of Tumors/Masses:
Types of Contrast Enhancement:
1. Homogeneous Enhancement:
  • Uniform enhancement throughout the mass
  • Seen in: Meningioma (intracranial), acoustic schwannoma, lymphoma, carcinoid
  • Indicates uniform vascularity and intact blood-brain barrier breakdown
2. Ring (Peripheral/Rim) Enhancement:
  • Enhancing rim with non-enhancing center (necrotic/cystic center)
  • Seen in:
    • High-grade glioma (GBM) - thick, irregular ring
    • Brain abscess - thin, smooth ring
    • Metastasis - thick irregular ring
    • MS plaques - "open ring" sign (incomplete ring)
    • Lymphoma - ring or homogeneous
    • Tumefactive MS - "open ring" sign (open towards cortex)
3. Heterogeneous Enhancement:
  • Mixed pattern due to necrosis, cysts, hemorrhage
  • Seen in: GBM, metastases, mixed germ cell tumors
4. No Enhancement:
  • Intact blood-brain barrier
  • Seen in: Low-grade glioma, epidermoid cyst, arachnoid cyst
5. Nodular Enhancement:
  • Discrete nodule(s) with enhancement
  • Seen in: Pilocytic astrocytoma (enhancing mural nodule in cystic tumor), hemangioblastoma
6. Dural Tail Enhancement:
  • Linear enhancement of adjacent dura
  • Seen in: Meningioma (pathognomonic but not specific)
7. Leptomeningeal Enhancement:
  • Sulcal/pial enhancement
  • Seen in: Meningitis, leptomeningeal carcinomatosis, sarcoidosis
8. Perilesional Enhancement:
  • Enhancement of surrounding tissue
  • Active inflammation around abscess
Specific Patterns for Common Brain Masses:
MassEnhancement Pattern
GBMThick, irregular ring; central necrosis
MetastasisThick ring or homogeneous; at gray-white junction
Brain abscessThin, smooth, complete ring; uniform thickness
MeningiomaHomogeneous; dural tail sign
LymphomaHomogeneous (immunocompetent); ring (immunocompromised)
Pilocytic astrocytomaEnhancing mural nodule + cyst
HemangioblastomaIntense enhancing nodule + cyst (posterior fossa)
MS plaque"Open ring" sign (horseshoe)

b. 40-year-old Woman with Unilateral Nipple Discharge - Imaging Workup

Note: "aute yr old women with unilateral discharge" is interpreted as "40-year-old woman with unilateral nipple/breast discharge"
Unilateral nipple discharge in a 40-year-old woman is a significant symptom requiring systematic workup.

Causes to consider:
  • Intraductal papilloma (most common cause of unilateral, bloody/serous discharge)
  • Ductal ectasia
  • Breast carcinoma (especially ductal carcinoma)
  • Papillomatosis
  • Fibrocystic change

Step 1: MAMMOGRAPHY
Bilateral (digital mammography - FFDM):
  • Retroareolar region - focused evaluation of subareolar ducts
  • Findings suggesting intraductal lesion:
    • Retroareolar density/mass
    • Ductal dilation
    • Intraductal calcification (rod-shaped, secretory)
    • Duct ectasia (tubular densities converging on nipple)
    • Intraluminal mass/calcification
  • Post-contrast digital mammography if standard is inconclusive

Step 2: ULTRASOUND (Primary modality for unilateral discharge)
  • High-frequency linear probe (10-15 MHz)
  • Focused retroareolar/subareolar scan
  • Intraductal papilloma:
    • Dilated duct with intraluminal echogenic nodule/mass
    • Duct diameter >2mm = abnormal
    • Color Doppler: Vascularity within papilloma
    • Heterogeneous intraductal lesion
  • Ductal ectasia: Dilated, tortuous retroareolar ducts without mass
  • Malignancy: Irregular hypoechoic mass; ductal involvement; axillary adenopathy
  • Compression over the subareolar area may reproduce discharge during scan

Step 3: GALACTOGRAPHY / DUCTOGRAPHY (Conventional)
  • Cannulation of discharging duct orifice with fine (30G) cannula
  • Injection of water-soluble contrast (0.1-0.5 mL)
  • Imaging in CC and lateral projections
  • Findings:
    • Intraductal filling defect = papilloma (smooth, round intraluminal filling defect)
    • Cut-off/obstruction = carcinoma or large papilloma
    • Duct irregularity = papillomatosis or DCIS
    • Normal duct = benign (ductal ectasia)
  • Limitation: Painful; operator-dependent; being replaced by MRI

Step 4: MRI BREAST (MR Galactography / Contrast-enhanced MRI)
Indications in unilateral discharge: When USG and mammography are equivocal; pre-surgical planning; occult lesion.
Protocol:
  • 1.5T or 3T; bilateral breast coil
  • T2W: Ductal anatomy; fluid/cysts
  • Fat-suppressed T1W pre and post-gadolinium (dynamic subtraction series)
  • DWI: Lesion characterization
MR Ductography / MR Galactography:
  • Heavily T2-weighted sequence (without contrast)
  • Shows dilated ducts as bright tubular structures
  • Intraductal masses as filling defects
Contrast-enhanced MRI findings:
  • Papilloma: Enhancing intraductal nodule with kinetic curve (rapid initial uptake, plateau/washout)
  • DCIS: Non-mass enhancement - linear/segmental clumped enhancement along duct
  • Invasive carcinoma: Irregular enhancing mass; rapid initial uptake + washout kinetics (Type III curve)
  • Ductal ectasia: Non-enhancing dilated ducts

Step 5: INTERVENTIONAL PROCEDURES
  • Ductoscopy: Direct microendoscopic visualization of discharging duct; biopsy
  • USG-guided core biopsy: For discrete lesions visible on ultrasound
  • Vacuum-assisted biopsy (stereotactic): For calcifications
  • Surgical excision (microdochectomy): If imaging-negative but discharge persists, or confirmed papilloma

Algorithm Summary for 40-year-old with Unilateral Nipple Discharge:
Clinical examination + discharge cytology
        ↓
Mammography (bilateral FFDM)
        ↓
Targeted Breast Ultrasound (subareolar)
        ↓
If lesion found: USG-guided biopsy
If no lesion: Galactography / MR ductography
        ↓
Lesion identified → Core biopsy / Ductoscopy
        ↓
Surgical excision if papilloma/malignancy confirmed

These are complete theory answers for JUNE 2026 Radiology Paper 1. All standard imaging modalities, sequences, findings, and classifications have been covered as required by a university examination standard.

Radiology university exam theory write full answers properly with missing any details and points detailed answer writing

Asking for Preferences
Please go ahead and upload the image of the question paper whenever you're ready! Once I receive it, I'll write complete, detailed theory answers for every question.

Question 10 is non mass enhancement please correct it


QUESTION 10 (Corrected)

a. Non-Mass Enhancement (NME) on Breast MRI (5 marks)

Definition: Non-mass enhancement (NME) refers to an area of contrast enhancement on breast MRI that does not form a discrete three-dimensional mass. It occupies a region of tissue where the normal background architecture is preserved between enhancing foci. It is an important MRI finding because it frequently represents DCIS or invasive carcinoma.

ACR BI-RADS Lexicon for NME

NME is described using three descriptors:
1. Distribution 2. Internal Enhancement Pattern

1. DISTRIBUTION of NME

DistributionDescriptionSignificance
FocalSmall area (<25% of a quadrant), not conforming to a ductUsually benign; can be fibrocystic change
LinearEnhancement in a line, may branchSuspicious - suggests ductal distribution (DCIS)
SegmentalTriangular/cone-shaped area pointing toward nippleHigh suspicion - represents ductal system; most associated with DCIS
RegionalLarge area (>25% quadrant) not duct-basedIntermediate suspicion
Multiple regionsAt least 2 large areas in same or both breastsMay be bilateral benign or multifocal malignancy
DiffuseRandomly distributed throughout breastUsually benign (hormonal, background)

2. INTERNAL ENHANCEMENT PATTERN of NME

PatternDescriptionSignificance
HomogeneousUniform, confluent enhancementCan be malignant or benign
HeterogeneousVariable, non-uniform enhancementMore suspicious
ClumpedCobblestone/cluster of grape-like fociHIGH suspicion - most associated with DCIS and invasive carcinoma
Clustered ringRim-enhancing small foci grouped togetherHigh suspicion - often malignant (invasive lobular carcinoma, DCIS)

Kinetic Curve Analysis in NME

  • Type I (Progressive): Gradual rise - favors benign
  • Type II (Plateau): Rise then flat - intermediate
  • Type III (Washout): Rise then fall - favors malignancy
  • Note: Kinetics are less reliable in NME compared to mass lesions; morphology and distribution dominate the assessment

Pathological Correlates of NME

NME PatternMost Likely Pathology
Segmental + clumpedDCIS (ductal carcinoma in situ)
Linear + branchingDCIS (high-grade, comedo type)
Regional + heterogeneousInvasive lobular carcinoma
Focal + homogeneousFibrocystic change, adenosis
Diffuse + homogeneousHormonal/physiological, mastitis
Clustered ringInvasive carcinoma, DCIS

MRI Protocol for NME Evaluation

  • 1.5T or 3T with dedicated bilateral breast coil
  • T1W fat-suppressed pre-contrast: Baseline
  • Dynamic DCE (T1W+Gd): Early (90 sec), delayed (3-5 min) post-contrast
  • Subtraction images: Removes background fat signal; highlights enhancement
  • T2W: Assess for associated cysts, edema
  • DWI/ADC: Restricted diffusion (low ADC) in malignant NME; ADC <1.2 x 10⁻³ mm²/s suspicious
  • MIP (Maximum Intensity Projection): 3D overview of all enhancement

Differential Diagnosis of NME

Malignant causes:
  • DCIS (most common malignant cause of NME)
  • Invasive ductal carcinoma (IDC) - non-mass pattern
  • Invasive lobular carcinoma (ILC) - frequently presents as NME
  • Inflammatory carcinoma
Benign causes:
  • Fibrocystic change / adenosis
  • Fibrocystic changes with usual ductal hyperplasia
  • Mastitis / inflammatory change
  • Sclerosing adenosis
  • Fat necrosis (post-surgical/post-radiation)
  • Hormonal enhancement (normal background parenchymal enhancement)
  • Fibroadenomatosis

BI-RADS Assessment and Management

BI-RADSRecommendation
3 (Probably benign - focal homogeneous)6-month follow-up MRI
4 (Suspicious - linear/segmental/clumped/clustered ring)Biopsy recommended
5 (Highly suspicious)Biopsy mandatory

Key Distinguishing Points: NME vs. Mass

FeatureMassNon-Mass Enhancement
Shape3D, displaces tissueNo discrete shape
ArchitectureDistorts surroundingsPreserves background architecture
MarginsDefined (smooth/irregular)Not applicable
DistributionLocalizedDescribed by distribution pattern
Most common malignancyIDCDCIS, ILC
KineticsReliableLess reliable; morphology dominant

Clinical Importance

  • NME accounts for approximately 15-30% of all enhancing lesions on breast MRI
  • Malignancy rate in NME: 25-40% overall
  • Segmental + clumped pattern carries the highest malignancy risk (~70-80%)
  • Linear distribution along duct = strong suspicion for DCIS
  • MRI-guided vacuum-assisted biopsy is the standard for NME not visible on second-look ultrasound or mammography

b. 40-year-old Woman with Unilateral Nipple Discharge - Imaging Workup

(This part remains as previously answered in full detail - please refer to the answer above)

This is the fully corrected and detailed answer for Non-Mass Enhancement (NME) as a breast MRI topic, covering BI-RADS lexicon, distribution patterns, internal enhancement patterns, kinetics, pathological correlates, differentials, and clinical management - all points required for a university radiology theory exam.
This is a shared conversation. Sign in to Orris to start your own chat.